Je was op zoek naar: systolic (Engels - Maltees)

blood pressure systolic increased
Żieda tal-pressjoni sistolika

systolic blood pressure > 160 mm hg
pressjoni tad-demm sistolika ta’ > 160 mm hg

systolic blood pressure higher than 160 mmhg
pressjoni tad- demm sistolika ogħla iktar minn 160 mmhg

systolic blood pressure at entry > 160 mmhg
pressjoni tad-demm sistolika ta’ > 160 mmhg meta jkun deċiż it-trattament

systolic bp ≥160 mmhg or diastolic bp ≥100 mmhg
bp sistolika ta’ ≥160 mmhg jew bp dijastolika ta’ ≥100 mmhg

mean pulmonary systolic blood pressure decreased by 9 %.
il-pressjoni medja tad-demm sistolika tal-pulmun naqset b’ 9 %.

18 recovery of baseline systolic blood pressure (sbp).
hemm tendenza apparenti għal relazzjoni bejn doża u l- ħin ta ’ l- irkupru tal- linja bażi tal- pressjoni sistolika tad- demm (sbp).

does the patient have a systolic blood pressure < 100 mm hg?
il-pazjent għandu pressjoni sistolika ta’ < 100 mm hg?

history of, or current heart failure or left ventricular systolic dysfunction
passat mediku ta’ insuffiċjenza tal-qalb jew li qegħda sseħħ bħalissa jew disfunzjoni sistolika fil-ventriklu tax-xellug

elevation of systolic and diastolic blood pressure was observed in rats and dogs.
Żieda fil-pressjoni sistolika u dijastolika tad-demm dehret fil-firien u l-klieb.

blood pressure diastolic decreased, blood pressure systolic increased, hypotension,
tnaqqis fil-pressjoni dijastolika tad-demm, żieda fil- pressjoni sistolika tad-demm, pressjoni baxxa, pressjoni għolja

decrease in systolic and diastolic blood pressures has been reported with ambrisentan therapy.
tnaqqis fil-pressjoni sistolika u dijastolika kien irrappurtat b’terapija ta’ ambrisentan.

patients should be followed for the development of left ventricular systolic dysfunction during treatment.
pazjenti għandhom jiġu segwiti għall-iżvilupp ta’ disfunzjoni sistolika fil-ventriklu tax-xellug waqt il- kura.

patients with systolic blood pressure over 160 mmhg have a greater risk of bleeding in the brain.
pazjenti bi pressjoni tad-demm sistolika ta’ aktar minn 160 mmhg għandhom riskju ikbar ta’ ħruġ tad- demm fil-moħħ.

in patients with hypertension telmisartan reduces both systolic and diastolic blood pressure without affecting pulse rate.
f’pazjenti bi pressjoni għolja, telmisartan inaqqas kemm il-pressjoni sistolika u dik dijastolika, mingħajr ma jaffettwa r-rata tal-polz.

systolic blood pressure over 160 mmhg before thrombolysis with reteplase was associated with greater risk for cerebral bleeding.
pressjoni tad-demm sistolika ta’ aktar minn 160 mmhg qabel it-trombolożi ma’ reteplase kienet assoċjata ma’ riskju ikbar għall-ħruġ tad-demm ċerebrali.

the mean maximum decreases in supine systolic blood pressure following 100 mg oral dosing of sildenafil was 8.4 mmhg.
l-ogħla tnaqqis medju fil-pressjoni sistolika f’pożizzjoni minduda wara 100 mg ta’ sildenafil doża orali kien ta’ 8.4 mmhg.

- if you have severe pulmonary hypertension (systolic pulmonary artery pressure > 90 mm hg).
- jekk għandek ipertensjoni qawwija fil- pulmun (pressjoni sistolika ta 'l- arterja tal- pulmun > 90 mm

blood pressure diastolic decreased, blood pressure increased, blood pressure systolic increased, haemoglobin decreased, heart rate increased
tnaqqis fil-pressjoni dijastolika tad-demm, żieda fil-pressjoni tad-demm, żieda fil- pressjoni sistolika tad-demm, tnaqqis fl- emoglobina, żieda fit-taħbit tal-qalb

severe hypertension (> 200 mmhg systolic or 110 mmhg diastolic) occurred in 4.7% of this patient population.
pressjoni għolja qawwija (> 200 mmhg sistolika jew 110 mmhg dijastolika) seħħew f’ 4. 7% ta ’ din il - popolazzjoni ta ’ pazjenti.